GetTopicDetailResponse(id=a872695382, topicName=Erleada, introduction=Erleada, content=null, image=null, comments=4, allHits=1392, url=https://h5.medsci.cn/topic?id=6953, type=1, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=94588, tagList=[TagDto(tagId=94588, tagName=Erleada)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=1353199, encodeId=efd0135319937, content=<a href='/topic/show?id=a872695382' target=_blank style='color:#2F92EE;'>#Erleada#</a>, objectTitle=ASCO GU 2021：ERLEADA聯(lián)合ZYTIGA治療轉(zhuǎn)移性去勢(shì)抵抗性前列腺癌III期臨床, objectType=article, longId=207001, objectId=7c4620e00147, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7c4620e00147, replyNumber=0, likeNumber=91, createdTime=2021-02-11, rootId=0, userName=zhaojie88, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7c4620e00147, moduleTitle=ASCO GU 2021：ERLEADA聯(lián)合ZYTIGA治療轉(zhuǎn)移性去勢(shì)抵抗性前列腺癌III期臨床, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=7c4620e00147)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1353198, encodeId=930413531987f, content=<a href='/topic/show?id=a872695382' target=_blank style='color:#2F92EE;'>#Erleada#</a>, objectTitle=強(qiáng)生的雄激素受體拮抗劑Erleada，獲得歐洲藥品管理局批準(zhǔn)治療去勢(shì)敏感型前列腺癌, objectType=article, longId=187284, objectId=4eb418e284e5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4eb418e284e5, replyNumber=0, likeNumber=91, createdTime=2020-02-04, rootId=0, userName=zhaojie88, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4eb418e284e5, moduleTitle=強(qiáng)生的雄激素受體拮抗劑Erleada，獲得歐洲藥品管理局批準(zhǔn)治療去勢(shì)敏感型前列腺癌, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=4eb418e284e5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1353197, encodeId=7b33135319eeb, content=<a href='/topic/show?id=a872695382' target=_blank style='color:#2F92EE;'>#Erleada#</a>, objectTitle=強(qiáng)生的雄激素受體抑制劑Erleada獲得FDA批準(zhǔn)，治療轉(zhuǎn)移性去勢(shì)敏感性前列腺癌, objectType=article, longId=179672, objectId=33491e967221, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=33491e967221, replyNumber=0, likeNumber=113, createdTime=2019-09-20, rootId=0, userName=zhaojie88, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=33491e967221, moduleTitle=強(qiáng)生的雄激素受體抑制劑Erleada獲得FDA批準(zhǔn)，治療轉(zhuǎn)移性去勢(shì)敏感性前列腺癌, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=33491e967221)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1353196, encodeId=9fbb13531964b, content=<a href='/topic/show?id=a872695382' target=_blank style='color:#2F92EE;'>#Erleada#</a>, objectTitle=歐盟委員會(huì)批準(zhǔn)前列腺癌新藥Erleada（apalutamide）：口服雄激素受體抑制劑, objectType=article, longId=159087, objectId=b24b15908e2c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b24b15908e2c, replyNumber=0, likeNumber=91, createdTime=2019-01-29, rootId=0, userName=zhaojie88, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b24b15908e2c, moduleTitle=歐盟委員會(huì)批準(zhǔn)前列腺癌新藥Erleada（apalutamide）：口服雄激素受體抑制劑, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=b24b15908e2c)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯話(huà)題小助手
2020-05-29
